Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

NIH HIV immunoassay licensed to IGEN

Dec. 23, 1996

Pharmacyclics' MRI contrast agent deemed approvable

Dec. 20, 1996

Licensees sought for MAbs specific for P-450 enzymes

Dec. 20, 1996

Licenses offered for marker in the human iNOS gene promoter region

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Dec. 18, 1996

Beacon obtains rights to Centocor tumor markers

Dec. 18, 1996

New imaging agents for 19F MRI claimed by Molecular Biosystems

Dec. 17, 1996

CRC and Cortecs to develop cancer diagnostic tests

Dec. 16, 1996

Oncogene Science and Bayer initiate cancer diagnostics collaboration

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...